Varenicline May Improve Smoking Cessation Rates Among Patients With MDD
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
Daily or weekly smokers were recruited via advertisements and randomly assigned to receive either a personalized or nonpersonalized text message intervention.
A team of investigators sought to determine whether alcohol consumption or cigarette smoking contributed to the risk of developing psoriasis among postmenopausal women.
Participants were randomly assigned into 4 groups: machine learning (ML) messaging plus viral toolkit, ML messaging without viral toolkit, standard messaging plus viral toolkit, and standard messaging without viral toolkit.
The researchers combined virtual reality with Approach Bias Modification to determine if this would improve smokers’ motivation to quit smoking and reduce the number of dropouts from smoking cessation programs.